Ceftriaxone sulbactam versus random antibiotic treatment in early age children with community-acquired pneumonia
Автор: Sadikov N., Akhrorkhonov R., Yakhudayev E.M.
Журнал: Экономика и социум @ekonomika-socium
Рубрика: Основной раздел
Статья в выпуске: 6-2 (97), 2022 года.
Бесплатный доступ
The purpose of the study was to assess the efficiency of starting empirical treatment with Ceftriaxone sulbactam in children under 3 years in-hospital with a verified diagnosis of severe community-acquired pneumonia. The study is retrospective. The analysis of 65 case histories of patients who were admitted in ARMCCH (Uzbekistan, Andijan), from 2021 to 2022 was made. The clinical efficacy of Ceftriaxone was 68.7% in severe community-acquired pneumonia in children under 3 years. Cef SLB therapy may be helpful for reducing mortality and morbidity of early age children with CAP.
Ceftriaxone sulbactam, pneumonia, children, treatment, efficacy
Короткий адрес: https://sciup.org/140300461
IDR: 140300461
Список литературы Ceftriaxone sulbactam versus random antibiotic treatment in early age children with community-acquired pneumonia
- Sadikov N, Yue XC, Hong XZ, Odilov B, Hua ZZ. The Effectiveness of Using Prednisolone in Children with Community - Acquired Pneumonia. Asian J Pediatr Res. 2021;5(3):1-8.
- Yanagihara K, Kadota J, Aoki N, Matsumoto T, Yoshida M, Yagisawa M, et al. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2010: general view of the pathogens' antibacterial susceptibility. J Infect Chemother. 2015;21(6):410-20.
- Niki Y, Hanaki H, Yagisawa M, Kohno S, Aoki N, Watanabe A, et al. The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibility. J Infect Chemother. 2008;14(4):279-90.
- American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416.
- Kohno S, Imamura Y, Shindo Y, Seki M, Ishida T, Teramoto S, et al. Clinical practice guidelines for nursing- and healthcare-associated pneumonia (NHCAP) [complete translation]. Respir Investig. 2013;51(2):103 -26.
- RS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society. Eur Respir J. 1998;11(4):986-91.
- Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000;31(2):347 -82.
- Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163(7):1730-54.
- Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243-50.
- Communiy-acquired pneumonia in children. Clinical Recommendations. Moskva:Original-maket; 2015. 64 p. Russian
- Maydannik VG. Clinical Recommendations on prevention and treatment of complications of acute respiratory infections in children. K. 2016;56 p. Russian
